The Asia Pacific Interventional Pulmonology Market would witness market growth of 7.9% CAGR during the forecast period (2023-2029).
Bronchoscopy, like other open-airway procedures and aerosol-generating procedures, provides a considerable danger of spreading contaminated droplets. Interventional pulmonologists are adjusting to high-risk treatments to protect patients and other medical personnel. Since there is a substantial risk of developing the novel virus even after two vaccination doses, interventional pulmonologists, and other stakeholders in the value chain are preserving optimal medical services to enhance clinical results.
Advanced bronchoscopy techniques, such as electromagnetic navigation bronchoscopy, supplement conventional bronchoscopy using a 3D lung map with real-time information. Electromagnetic navigation bronchoscopy is anticipated to safeguard higher reimbursements, driving the expansion of the interventional pulmonology market. Companies like Olympus are continually developing new products in the interventional pulmonology market. Similarly, businesses struggle to create and obtain regulatory authorization for novel methods and solutions.
India is among the most populated nations in the world, and a significant portion of its population is 60 or older. Furthermore, it is anticipated that India's elderly population will continue to grow. According to government estimates, the ratio will rise from 7.5% in 2010 reach 11.1% in 2025. One of the world's populations that are aging at the fastest rate is China. By 2040, there will be 28% of individuals in China who are over 60 as a result of rising life expectancy and falling fertility rates. In particular, creating an integrated system that meets the social & health needs of older people while ensuring that everyone has access to healthcare, regardless of location, is one of the many new opportunities and challenges this profound demographic shift presents for public health and economic growth.
The China market dominated the Asia Pacific Interventional Pulmonology Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $430.5 million by 2029. The Japan market is estimated to grow a CAGR of 7.3% during (2023 - 2029). Additionally, The India market would experience a CAGR of 8.6% during (2023 - 2029).
Based on Product, the market is segmented into Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Bronchial Thermoplasty Systems, Pleuroscopes, Respiratory Endotherapy Devices, Endobronchial Valves and Airway Stents & Pleural Catheters. Based on Indication, the market is segmented into Asthma, Lung Cancer, COPD, Tracheal & Bronchial Stenosis and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Interventional Pulmonology Market is Projected to reach USD 5.9 Billion by 2029, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Becton, Dickinson and Company, Olympus Corporation, Fujifilm Holdings Corporation, ICU Medical, Inc. (Smiths Medical), HUGER Medical Instrument Co., Ltd, Cook Medical, Inc. (Cook Group), Clarus Medical LLC and Vygon SAS.
By Product
By Indication
By End-user
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
